Answers are grounded in this paper and cite their sources.
Objectives This study aimed to identify transcriptomic biomarkers for gastric low-grade intraepithelial neoplasia (LGIN), validate the lead candidate at the protein level in clinical LGIN biopsy specimens, and preliminarily evaluate its expression in intestinal metaplasia (IM). Methods Differentially expressed genes between chronic gastritis and LGIN in GSE130823 were screened using least absolute shrinkage and selection operator (LASSO), support vector machine–recursive feature elimination (SVM-RFE), and weighted gene co-expression network analysis (WGCNA). The lead candidate was validated in GSE55696 and subsequently evaluated by immunohistochemistry in clinical LGIN biopsies. Its expression in chronic atrophic gastritis with intestinal metaplasia (CAG-IM) tissues and an in vitro IM model was examined exploratorily. Results Among 328 differentially expressed genes, claudin-3 ( CLDN3 ) was the sole candidate shared by all three feature-selection methods and distinguished LGIN from chronic gastritis with areas under the receiver operating characteristic curves (AUCs) of 0.938 and 0.903 in the training and validation datasets, respectively. At the protein level, CLDN3 expression was significantly higher in LGIN than in chronic superficial gastritis (CSG) (adjusted p=0.005) and distinguished LGIN from CSG with an AUC of 0.804 (95 % confidence interval [CI], 0.646–0.962). The LGIN vs. CSG difference remained significant after adjustment for Helicobacter pylori ( H. pylori ) status, age, and sex. Exploratory analyses showed that CLDN3 was also elevated in CAG-IM tissues and the in vitro IM model. Conclusions This study identified and validated CLDN3 as a candidate biomarker for LGIN. Its concordant upregulation in CAG-IM tissues additionally suggests that CLDN3 may serve as a broader marker across the gastric precancerous continuum. The persistence of the LGIN vs. CSG difference after accounting for H. pylori status and in H. pylori -negative specimens argues against H. pylori -associated inflammation as a major confounder of the observed CLDN3 elevation.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: